Page last updated: 2024-08-24

pinocembrin and Pneumonia

pinocembrin has been researched along with Pneumonia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cui, M; Cui, Y; Gan, W; Helian, K; Li, X; Liu, R; Ning, W; Ren, S; Wang, M; Wei, Y; Xiao, T; Yang, C; Zhou, H	1

Other Studies

1 other study(ies) available for pinocembrin and Pneumonia

Article	Year
Pinocembrin relieves lipopolysaccharide and bleomycin induced lung inflammation via inhibiting TLR4-NF-κB-NLRP3 inflammasome signaling pathway. International immunopharmacology, 2021, Volume: 90 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Flavanones; Inflammasomes; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4	2021

Article

Year

Pinocembrin relieves lipopolysaccharide and bleomycin induced lung inflammation via inhibiting TLR4-NF-κB-NLRP3 inflammasome signaling pathway.

International immunopharmacology, 2021, Volume: 90

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bleomycin; Flavanones; Inflammasomes; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4

2021